Traphaco JSCSTC:TRA -0.13%83 Net Margin % is 9.74% as of Mar. 2026, which is 6% below its 10-year median of 10.40. GuruFocus rates STC:TRA with a GF Score™ of 83/100 and a GF Value™ of ₫92,290.93 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Traphaco JSC ranks better than 62.97% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Traphaco JSC's Net Income for the
three
months ended in Mar. 2026 was ₫61,613 Mil. Traphaco JSC's Revenue for the
three
months ended in Mar. 2026 was ₫632,847 Mil. Therefore, Traphaco JSC's net margin for the quarter that ended in Mar. 2026 was 9.74%.
The historical rank and industry rank for Traphaco JSC's Net Margin % or its related term are showing as below:
STC:TRA'
s Net Margin % Range Over the Past 10 Years
Min: 8.69 Med: 10.4 Max: 12.89
Current: 9.76
STC:TRA's Net Margin % is ranked better than 62.97% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs STC:TRA: 9.76
Traphaco JSC (STC:TRA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Traphaco JSC Net Margin % Related Terms
Traphaco JSC Net Margin % Historical Data
* Premium members only.
The historical data trend for Traphaco JSC's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Traphaco JSC Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's Net Margin % distribution charts can be found below:
* The bar in red indicates where Traphaco JSC's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Traphaco JSC (STC:TRA) has a Net Margin % of 9.74% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Traphaco JSC and its competitors. This is near median its historical median of 10.40. Over the past decade, Traphaco JSC's Net Margin % has ranged from 8.69 to 12.89. According to the industry distribution chart, Traphaco JSC ranks #354 out of 956 companies in the Drug Manufacturers industry, placing it in the top 37%.
Is Traphaco JSC's Net Margin % too high?
Traphaco JSC's current Net Margin % of 9.74% is near median its 10-year median of 10.40. Over the past 10 years, this metric has ranged from a low of 8.69 to a high of 12.89. The Drug Manufacturers industry median Net Margin % is 5.56. Traphaco JSC's value of 9.74% is 75.2% above this industry median. Based on the distribution chart, Traphaco JSC ranks #354 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Traphaco JSC has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Traphaco JSC ranks #354 out of 956 companies for Net Margin %. This puts Traphaco JSC in the upper half of its industry. The industry median Net Margin % is 5.56. Traphaco JSC's value of 9.74% is 75.2% above this benchmark. Historically, Traphaco JSC's own Net Margin % has ranged from 8.69 to 12.89 over the past decade. While the company's 10-year median is 10.40 vs. the industry median of 5.56, Traphaco JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Traphaco JSC's current Net Margin % of 9.74% is 75.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Traphaco JSC and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Traphaco JSC's current Net Margin % is 9.74%, which is near median its own 10-year median of 10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,290.93, compared to a current price of ₫77,900.00 — trading 15.6% below its estimated fair value. The current Net Margin % is 9.74%, which is near median its 10-year median of 10.40 and 75.2% above the Drug Manufacturers industry median of 5.56. Traphaco JSC's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current Net Margin % is 9.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫77,900.00 is trading 15.6% below its estimated GF Value™ of ₫92,290.93.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
Net Margin %: 9.74% (near median its 10-year median of 10.40)
GF Value™: ₫92,290.93 vs. price of ₫77,900.00 (15.6% below fair value)
Industry Position: 75.2% above the Drug Manufacturers median (#354 of 956)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
83GF Score
Get the complete analysis for STC:TRA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
